Effects of hyperoxia on VEGF, its receptors, and HIF-2α in the newborn rat lung

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 1 29-1, 2003, Pages

  Hosford, Gayle E ^a   Olson, David M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Alveolarization; Oxygen; Septation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; OXYGEN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HYPEROXIA; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; LUNG PARENCHYMA; MALE; NEWBORN; NONHUMAN; OXYGEN CONCENTRATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

EID: 0037662638     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00285.2002     Document Type: Article

References (35)

1. Akeno N, Czyzyk-Krzeska MF, Gross TS, and Clemens TI. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha. Endocrinology 142: 959-962, 2001.
2. Becker PM, Verin AD, Booth MA, Liu F, Birukova A, and Garcia JG. Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 281: L1500-L1511, 2001.
3. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, and Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
4. Boros V, Burghardt JS, Morgan CJ, and Olson DM. Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats. Am J Physiol Lung Cell Mol Physiol 272: L433-L441, 1997.
5. Brown KR, England KM, Goss KL, Snyder JM, and Acarregui MJ. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281: L1001-L1010, 2001.
6. Burghardt JS, Boros V, Biggs DF, and Olson DM. Lipid mediators in oxygen-induced airway remodeling and hyperresponsiveness in newborn rats. Am J Respir Crit Care Med 154: 837-842, 1996.
7. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, and Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002.
8. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, and Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 18: 1905-1914, 1999.
9. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, and Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor lalpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94: 4273-4278, 1997.
10. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280: C1358-C1366, 2001.
11. Ferrara N and Bunting S. Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 5: 35-44, 1996.
12. Fong GH, Rossant J, Gertsenstein M, and Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995.
13. Fong GH, Zhang L, Bryce DM, and Peng J. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126: 3015-3025, 1999.
14. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
15. Jobe AH and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723-1729, 2001.
16. Kauffman SL, Burri PH, and Weibel ER. The postnatal growth of the rat lung. II. Autoradiography. Anat Rec 180: 63-76, 1974.
17. Klekamp JG, Jarzecka K, and Perkett EA. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am J Pathol 154: 823-831, 1999.
18. Kovar J, Sly PD, and Willet KE. Inhaled Corticosteroids And Early Postnatal Lung Development. American Thoracic Society 2002, 98th International Conference, Atlanta, Georgia, 2002.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
20. Maniscalco WM, Watkins RH, D'Angio CT, and Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16: 557-567, 1997.
21. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, and Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282: L811-L823, 2002.
22. Manji JS, O'Kelly CJ, Leung WI, and Olson DM. Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes. Am J Physiol Lung Cell Mol Physiol 281: L799-L806, 2001.
23. Massaro D, Teich N, Maxwell S, Massaro GD, and Whitney P. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest 76: 1297-1305, 1985.
24. Meyrick B and Reid L. Pulmonary arterial and alveolar development in normal postnatal rat lung. Am Rev Respir Dis 125: 468-473, 1982.
25. Muratore CS, Nguyen HT, Ziegler MM, and Wilson JM. Stretch-induced upregulation of VEGF gene expression in murine pulmonary culture: a role for angiogenesis in lung development. J Pediatr Surg 35: 906-913, 2000.
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: E45-E45, 2001.
27. Plouet J, Moro F, Bertagnolli S, Coldeboeuf N, Mazarguil H, Clamens S, and Bayard F. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem 272: 13390-13396, 1997.
28. Risau W. Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
29. Roberts RJ, Weesner KM, and Bucher JR. Oxygen-induced alterations in lung vascular development in the newborn rat. Pediatr Res 17: 368-375, 1983.
30. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 14: 1983-1991, 2000.
31. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, and Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66, 1995.
32. Thibeault DW, Mabry S, and Rezaiekhaligh M. Neonatal pulmonary oxygen toxicity in the rat and lung changes with aging. Pediatr Pulmonol 9: 96-108, 1990.
33. Watkins RH, D'Angio CT, Ryan RM, Patel A, and Maniscalco WM. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 276: L858-L867, 1999.
34. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze C, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, and Eckardt KU. Widespread, hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs (Abstract). FASEB J 17: 17, 2002.
35. Zeng X, Wert SE, Federici R, Peters KG, and Whitsett JA. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 211: 215-227, 1998.